Ohio Dental Ebook Continuing Education

Š National Institute on Drug Abuse. (n.d.d). NIDAMED: Medical & health professionals. Retrieved on July 1, 2019, from https://www.drugabuse.gov/nidamed-medical-health-professionals Š National Institute on Drug Abuse. (n.d.e). Over-the-counter medicines. Retrieved on July 5, 2019, from https://www.drugabuse.gov/drugs-abuse/over-counter-medicines Š National Institute on Drug Abuse. (n.d.f). Prescription medicines Retrieved on July 5, 2019, from https:// www.drugabuse.gov/drugs-abuse/prescription-medicines Š National Institute on Drug Abuse. (n.d.g). 2016-2020 NIDA Strategic Plan. Retrieved on July 5, 2019, from https://www.drugabuse.gov/about-nida/strategic-plan/nidas-mission Š National Institute on Drug Abuse. (2007). NIDA launches first large-scale national study to treat addiction to prescription pain medications. Retrieved from https://www.nih.gov/news-events/news-releases/nida- launches-first-large-scale-national-study-treat-addiction-prescription-pain-medications Š National Institute on Drug Abuse. (2011a). Analysis of opioid prescription practices finds areas of concern. Retrieved from https://archives.drugabuse.gov/news-events/news-releases/2011/04/analysis-opioid- prescription-practices-finds-areas-concern Š National Institute on Drug Abuse. (2011b). Commonly abused prescription drugs. Retrieved from https:// www.drugabuse.gov/sites/default/files/rx_drugs_placemat_508c_10052011.pdf Š National Institute on Drug Abuse. (2013). Substance abuse in the military. Retrieved from https://www. drugabuse.gov/publications/drugfacts/substance-abuse-in-military Š National Institute on Drug Abuse. (2014a). Centers of Excellence (COE) for physician information. Retrieved from https://www.drugabuse.gov/nidamed-medical-health-professionals/centers-excellence-coe-physician- information Š National Institute on Drug Abuse. (2014b). Principles of adolescent substance use disorder: A research- based guide. Retrieved from https://www.drugabuse.gov/publications/principles-adolescent-substance- use-disorder-treatment-research-based-guide/frequently-asked-questions/how-do-adolescents-become- addicted-to-drugs-which-factors-increase-risk Š National Institute on Drug Abuse (2016). Military. Retrieved from https://www.drugabuse.gov/related-topics/ military Š National Institute on Drug Abuse (2017). Trends & statistics. Retrieved from https://www.drugabuse.gov/ related-topics/trends-statistics Š National Institute on Drug Abuse (2018a). Benzodiazepines and opioids. Retrieved from https://www. drugabuse.gov/drugs-abuse/opioids/benzodiazepines-opioids Š National Institute on Drug Abuse. (2018b). Comorbidity: Substance use disorders and other mental illnesses. Retrieved from https://www.drugabuse.gov/publications/drugfacts/comorbidity-substance-use-disorders- other-mental-illnesses Š National Institute on Drug Abuse (2018c). How can prescription drug misuse be prevented? Retrieved from https://www.drugabuse.gov/publications/research-reports/misuse-prescription-drugs/how-can-prescription- drug-misuse-be-prevented Š National Institute on Drug Abuse (2018d). Is there a difference between physical dependence and addiction? Principles of drug addiction treatment: A research-based guide (3rd ed.). Retrieved from https:// www.drugabuse.gov/publications/principles-drug-addiction-treatment-research-based-guide-third-edition/ frequently-asked-questions/there-difference-between-physical-dependence Š National Institute on Drug Abuse. (2018e). National Survey on Drug Use and Health. Retrieved from https:// www.drugabuse.gov/national-survey-drug-use-health Š National Institute on Drug Abuse (2018f). Opioid overdose reversal with naloxone (Narcan, Evzio). Retrieved from https://www.drugabuse.gov/related-topics/opioid-overdose-reversal-naloxone-narcan-evzio Š National Institute on Drug Abuse. (2018g). Prescription opioids and heroin. Retrieved from https://www. drugabuse.gov/publications/research-reports/relationship-between-prescription-drug-abuse-heroin-use/ heroin-use-driven-by-its-low-cost-high-availability Š National Institute on Drug Abuse. (2018h). Prescription stimulants. Retrieved from https://www.drugabuse. gov/publications/drugfacts/prescription-stimulants Š National Institute on Drug Abuse. (2018i). What is the scope of prescription drug misuse? Retrieved from https://www.drugabuse.gov/publications/research-reports/misuse-prescription-drugs/what-scope- prescription-drug-misuse Š National Institute on Drug Abuse (2019a). Overdose death rates. Retrieved from https://www.drugabuse. gov/related-topics/trends-statistics/overdose-death-rates Š National Institute on Drug Abuse (2019b). Opioid overdose crisis. Retrieved from https://www.drugabuse. gov/drugs-abuse/opioids/opioid-overdose-crisis Š National Institute on Drug Abuse (2019c). Substance use in women. Retrieved from https://www.drugabuse. gov/publications/drugfacts/substance-use-in-women Š National Institutes of Health. (2018a). LiverTox: Clinical and research information on drug-induced liver injury. Retrieved from https://livertox.nih.gov/Acetaminophen.htm Š National Institutes of Health. (2018b). The NIH almanac: National Institute on Drug Abuse (NIDA). Retrieved from https://www.nih.gov/about-nih/what-we-do/nih-almanac/national-institute-drug-abuse-nida Š National Institutes of Health (2019). NIH HEAL Initiative. Retrieved from https://www.nih.gov/research- training/medical-research-initiatives/heal-initiative Š National Rx Drug Abuse & Heroin Summit. (n.d.). [Home]. Retrieved on July 6, 2019, from https://www. rx-summit.com/ Š New England High Intensity Drug Trafficking Area. (n.d.). About ONDCP. Retrieved on July 6, 2019, from https://www.nehidta.org/(X(1)S(bl45wmdjatlr1wbktwemkwq3))/default.aspx/MenuItemID/145/MenuGroup/ Home.htm Š NIDA for Teens. (2019a). Prescription depressant medications. Retrieved from https://teens.drugabuse.gov/ drug-facts/prescription-depressant-medications Š NIDA for Teens. (2019b). Prescription drugs. Retrieved from https://teens.drugabuse.gov/drug-facts/ prescription-drugs Š North Carolina Board of Pharmacy. (2017). Drug diversion pocket card. Retrieved from http://www.ncbop. org/faqs/DrugDiversionPocketCard.pdf Š Oakley, M., O’Donnell, J. A., Moore, P. A., & Martin, J. P. (2011). The rise in prescription drug abuse: Raising awareness in the dental community. Compendium of Continuing Education in Dentistry, 32(6), 14-22. Š Office of National Drug Control Policy. (n.d.a). [Home]. Retrieved on July 6, 2019, from https://www. whitehouse.gov/ondcp/ Š Office of National Drug Control Policy. (n.d.b). Collaborating with Native Americans and Alaskan Natives. Retrieved on June 29, 2019, from https://obamawhitehouse.archives.gov/ondcp/native-americans-and- alaskan-indians Š Office of National Drug Control Policy. (n.d.c). Prescription opioid misuse, heroin and fentanyl. Retrieved on July 6, 2019, from https://www.whitehouse.gov/ondcp/key-issues/prescription-opioid-misuse/ Š Office of National Drug Control Policy (2018). Ending America’s opioid crisis. Retrieved from https://www. whitehouse.gov/opioids/ Š Ornstein, C., & Jones, R. G. (2014, December 15). As controlled substance use rises in Medicare, prolific prescribers face more scrutiny. ProPublica. Retrieved from https://www.propublica.org/article/as-controlled- substance-use-rises-in-medicare-top-prescribers-face-scrutiny Š O’Toole, J. (2012, February 24). How prescription drug abuse costs you money. CNNMoney. Retrieved from https://money.cnn.com/2012/02/22/news/economy/prescription_drug_abuse/index.htm Š Pennsylvania Department of Health. (n.d.). PDMP questions and answers (q&a). Retrieved on July 3, 2019, from https://www.health.pa.gov/topics/programs/PDMP/Pages/QA.aspx Š Pergolizzi, J. V., Gharibo, C., Passik, S., Labhsetwar, S., Taylor, R., Pergolizzi, J. S., & Muller-Schwefe, G. (2012). Dynamic risk factors in the misuse of opioid analgesics. Journal of Psychosomatic Research, 72(6), 443-451. Š Pew Charitable Trusts (2017). The high price of the opioid crisis. Retrieved from https://www.pewtrusts. org/~/media/assets/2017/07/highpriceofopioidcrisis_infographic_final.pdf?la=en Š PharmacyChecker.com. (n.d.). Adderall. Retrieved on June 28, 2019, from https://www.pharmacychecker. com/adderall/?formulation=tablet Š Philadelphia Department of Behavioral Health and Intellectual Disability Services, Community Behavioral Health. (2018, July 30). Clinical guidelines for the prescribing and monitoring of benzodiazepines and related medications. Retrieved from https://dbhids.org/wp-content/uploads/2018/07/Clinical-Guidelines-for- Prescribing-and-Monitoring-Benzodiazepines.pdf Š Potter, M. (2015, May 20). Drug Enforcement Administration raids ‘pill mills’ in four southern states. Retrieved from http://www.nbcnews.com/news/us-news/drug-enforcement-administration-raids-pill-mills- four-southern-states-n361956 Š Providers’ Clinical Support System. (n.d.). [About]. Retrieved on July 3, 2019, from https://pcssnow.org/ about/ Š Prudhomme White, B., Grace-Bishop, K., & Ciali, L. (2016). Non-medical use of prescription stimulants among college students: An updated report. International Journal of Health Sciences, 4(1), 21-30. Š Regier, D. A., Framer, M. E., Rae, D. S., Locke, B. Z., Keith, S. J., Judd, L. L., & Goodwin, F. K. (1990). Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiologic catchment area (ECA) study. Journal of the American Medical Association, 264(19), 2511-2518. Š Riggs, P. (2008). Non-medical use and abuse of commonly prescribed medications. Current Medical Research and Opinion, 24(3), 869-877. Š RTI International. (2018). SAMHSA fact sheets on preventing prescription abuse in the workplace. Retrieved from https://www.rti.org/announcements/samhsa-fact-sheets-preventing-prescription-abuse-workplace Š Sacco, L. N., Duff, J. H., & Sarata, A. K. (2018). Prescription drug monitoring programs. Congressional Research Service. Retrieved from https://fas.org/sgp/crs/misc/R42593.pdf

Š Schaffer Library of Drug Policy. (n.d.). Legal references on drug policy. Retrieved on June 26, 2019, from http://druglibrary.org/schaffer/legal/legal1920.htm Š Schwartz, A. (2013, December 14). The selling of attention deficit disorder. The New York Times. Retrieved from http://www.nytimes.com/2013/12/15/health/the-selling-of-attention-deficit-disorder. html?pagewanted=all&_r=0 Š Seay, N. (2014, August 8). The polypharmacy overdose: A killer trend. Rehabs.com [American Addiction Centers]. Retrieved from https://www.rehabs.com/blog/the-polypharmacy-overdose-a-killer-trend/ Š Skolniek, P., & Poul, S. (1982). Benzodiazepine receptors in the central nervous system. International Review of Neurobiology, 23, 103-140. Š Slovic, P., Peters, E., Grana, J., Berger, S., & Dieck, G. (2007). Risk perception of prescription drugs: Results of a national survey. Drug Information Journal, 41, 81-100. Retrieved from https://pdfs.semanticscholar.org/ ff3a/cc486744524b4d28e11b32a466b6905c0633.pdf Š Stanford Children’s Health (2019). Cough medicine abuse by teens. Retrieved from https://www. stanfordchildrens.org/en/topic/default?id=cough-medicine-abuse-by-teens-1-2617 Š StreetRx.com. (n.d.). About StreetRx. Retrieved on June 28, 2019, from https://streetrx.com/ Š Strickland, J. M., Huskey, A., & Brushwood, D. B. (2007). Pharmacist-physician collaboration in pain management practice. Journal of Opioid Management, 3(6), 295-301. Š Substance Abuse and Mental Health Services Administration. (n.d.a). Behavioral health treatment services locator. Retrieved on July 6, 2019, from https://findtreatment.samhsa.gov Š Substance Abuse and Mental Health Services Administration. (n.d.b). Screening tools. Retrieved on July 6, 2019, from https://www.integration.samhsa.gov/clinical-practice/screening-tools Š Substance Abuse and Mental Health Services Administration. (2014a). Gender differences in primary substance of abuse across age groups. The TEDS Report. Retrieved from https://www.samhsa.gov/data/ sites/default/files/sr077-gender-differences-2014.pdf Š Substance Abuse and Mental Health Services Administration. (2014b). Results from the 2013 National Survey on Drug Use and Health. Retrieved from https://www.samhsa.gov/data/sites/default/files/ NSDUHresultsPDFWHTML2013/Web/NSDUHresults2013.pdf Š Substance Abuse and Mental Health Services Administration. (2017). Screening, Brief Intervention, and Referral to Treatment (SBIRT). Retrieved from https://www.samhsa.gov/sbirt Š Substance Abuse and Mental Health Services Administration. (2019). Rise in prescription drug misuse and abuse impacting teens. Retrieved from https://www.samhsa.gov/homelessness-programs-resources/hpr- resources/teen-prescription-drug-misuse-abuse Š Suda, K. J., Durkin, M. J., Calip, G. S., Gellad, W. F., Kim, H., Lockhart, P. B., … Thornhill, M. H. (2019). Comparison of Š opioid prescribing by dentists in the United States and England. JAMA Network Open, 2(5), e194303. doi:10.1001/jamanetworkopen.2019.4303. Š Tantibanchachai, C. (2018). US regulatory response to thalidomide (1950-2000). The Embryo Project Encyclopedia [Arizona State University]. Retrieved from https://embryo.asu.edu/pages/us-regulatory- response-thalidomide-1950-2000 Š Thielking, M. (2017, March 7). Missouri is the only state not monitoring prescription drug use. Will it finally create a database? STAT. Retrieved from https://www.statnews.com/2017/03/07/missouri-prescription-drug- database/ Š United Nations Office on Drugs and Crime. (2011). The non-medical use of prescription drugs: Policy direction issues. Retrieved from https://www.unodc.org/docs/youthnet/Final_Prescription_Drugs_Paper.pdf Š U.S. Department of Defense. (n.d.). Millennium Cohort Study: FAQ. Retrieved on July 6, 2019, from https:// www.millenniumcohort.org/faq Š U.S. Department of Health and Human Services (2017). Treatment Episode Data Set (TEDS) 2017 Admissions to and discharges from publicly-funded substance use treatment: 2017 TEDS Annual Report. Retrieved from https://www.samhsa.gov/data/sites/default/files/cbhsq-reports/TEDS-2017.pdf Š U.S. Department of Health and Human Services. (2019a). Opioids and adolescents. Retrieved from https:// www.hhs.gov/ash/oah/adolescent-development/substance-use/drugs/opioids/index.html Š U.S. Department of Health and Human Services. (2019b). What is the U.S. opioid epidemic? Retrieved from https://www.hhs.gov/opioids/about-the-epidemic/index.html Š U.S. Department of Justice, Office of Justice Programs, National Criminal Justice Reference Service. (n.d.). Anti-Drug Abuse Act of 1988 (H.R. 5210, 100th Congress: Highlights of enacted bill. Retrieved on June 26, 2019, from https://www.ncjrs.gov/App/publications/abstract.aspx?ID=143053 Š U.S. Department of Justice, Office of Justice Programs, National Institute of Justice. (2019). Florida legislation helps reduce the number of “pill mills.” Retrieved from https://nij.gov/topics/drugs/markets/ Pages/florida-legislation-helps-reduce-the-number-of-pill-mills.aspx Š U.S. Drug Enforcement Administration, (n.d.a). Diversion Control Division: Controlled substance schedules. Retrieved on June 26, 2019, from https://www.deadiversion.usdoj.gov/schedules Š U.S. Drug Enforcement Administration. (n.d.b). Diversion Control Division: Program de-scription. Retrieved on July 6, 2019, from https://www.deadiversion.usdoj.gov/prog_dscrpt/index.html Š U.S. Drug Enforcement Administration. (1999). Diversion Control Division: Don’t be scammed by a drug abuser. Retrieved from https://www.deadiversion.usdoj.gov/pubs/brochures/drugabuser.htm Š U.S. Drug Enforcement Administration. (2013). Office of Diversion Control: Benzodiazepines. Retrieved from https://www.deadiversion.usdoj.gov/drug_chem_info/benzo.pdf Š U.S. Drug Enforcement Administration. (2014). Diversion Control Division: Rules – 2014: 21 CFR Part 1308. Retrieved from https://www.deadiversion.usdoj.gov/fed_regs/rules/2014/fr0822.htm Š U.S. Food and Drug Administration. (2012). Kefauver-Harris Amendments revolutionized drug development. Retrieved from https://www.fda.gov/consumers/consumer-updates/kefauver-harris-amendments- revolutionized-drug-development Š U.S. Food and Drug Administration. (2015). The benefits and risks of pain relievers: Q & A on NSAIDs with Sharon Hertz, M.D. Retrieved from https://www.fda.gov/consumers/consumer-updates/benefits-and-risks- pain-relievers-q-nsaids-sharon-hertz-md Š U.S. Food and Drug Administration. (2018a). Approved risk evaluation and mitigation strategies (REMS). Retrieved from https://www.accessdata.fda.gov/scripts/cder/rems/index.cfm Š U.S. Food and Drug Administration. (2018b). Part II: 1938: Food, Drug, Cosmetic Act. Retrieved from https:// www.fda.gov/about-fda/fdas-evolving-regulatory-powers/part-ii-1938-food-drug-cosmetic-act Š U.S. Food and Drug Administration. (2019a). Disposal of unused medicines: What you should know. Retrieved from https://www.fda.gov/drugs/safe-disposal-medicines/disposal-unused-medicines-what-you- should-know Š U.S. Food and Drug Administration. (2019b). Part I: The 1906 Food and Drugs Act and its enforcement. Retrieved from https://www.fda.gov/about-fda/fdas-evolving-regulatory-powers/part-i-1906-food-and-drugs- act-and-its-enforcement Š U.S. House of Representatives. (n.d.). Historical highlights: The Pure Food and Drug Act (June 23, 1906). Retrieved on June 26, 2019, from https://history.house.gov/Historical-Highlights/1901-1950/Pure-Food-and- Drug-Act/ Š Volkow, N. D. (2008). Statement by Nora D. Volkow, MD, Director, National Institute on Drug Abuse, National Institutes of Health, U.S. Department of Health and Human Services. Retrieved from https://www. judiciary.senate.gov/imo/media/doc/volkow_testimony_03_12_08.pdf Š Volkow, N. D. (2010). Prescription drug abuse. Retrieved from https://archives.drugabuse.gov/ testimonies/2010/prescription-drug-abuse Š Volkow, N. D. (2014). America’s addiction to opioids: Heroin and prescription drug abuse. Retrieved from https://archives.drugabuse.gov/testimonies/2014/americas-addiction-to-opioids-heroin-prescription-drug- abuse Š Volkow, N. D., McLellan, T. A., Cotto, J. H., Karithanom, M., & Weiss, S. (2011). Characteristics of opioid prescriptions in 2009. Journal of the American Medical Association, 305(13), 1299-1301. Š Washington, State of, Dr. Robert Bree Collab-orative. (2017). Dental guideline on prescribing medication for acute pain management: September 2017. Retrieved from http://www.agencymeddirectors.wa.gov/Files/20 171026FINALDentalOpioidRecommendations_Web.pdf Š Wax, P. M. (1995). Elixirs, diluents, and the passage of the 1938 Federal Food, Drug and Cosmetic Act. Annals of Internal Medicine, 122(6), 456-461. Š Weber, L. (2019, May 20). Why Missouri’s the last holdout on a statewide Rx monitoring program. Kaiser Health News. Retrieved from https://khn.org/news/why-missouris-the-last-holdout-on-a-statewide-rx- monitoring-program/ Š Wentworth, R. B. (2008). What should I do when I suspect a patient may be abusing prescription drugs? Journal of the American Dental Association, 139(5), 623-624. Š West, J. G. (2018, January 16). Object lessons: The accidental poison that founded the modern FDA. The Atlantic. Retrieved from https://www.theatlantic.com/technology/archive/2018/01/the-accidental-poison- that-founded-the-modern-fda/550574/ Š White, A. G., Birnbaum, H. G., Mareva, M. N., Daher, M., Vallow, S., Schein, J., & Katz, N. (2005). Direct costs of opioid abuse in an insured population in the United States. Journal of Managed Care Pharmacy, 11(6), 469-479. Š Wick, J. Y. (2013). The history of benzodiazepines. The Consultant Pharmacist, 28(9), 538-548. Š Winters, K. C., & Arria, A. (2011). Adolescent brain development and drugs. Prevention Researcher, 18(2), 21-24. Š

Yoshida, M., Shimizu, Y., Yoshida, K., Mukai, A., Doi, M., & Irifune, M. (2018). Effective postoperative analgesia using intravenous flurbiprofen and acetaminophen. [Abstract]. Journal of Oral and Maxillofacial Surgery, 76(9), 1869-1872. PRESCRIPTION DRUG ABUSE AMONG DENTAL PATIENTS: SCOPE, PREVENTION, AND MANAGEMENT CONSIDERATIONS Final Examination Questions Select the best answer for each question complete your test online at EliteLearning.com/Book 1. In an effort to oversee enforcement of all controlled substance laws, the U.S. Drug Enforcement Administration (DEA) was created in: 3. The United States makes up only 4.6% of the world’s population, but uses what percentage of the global supply of opioid pain relievers?

a. 1973. b. 1970. c. 1963. d. 1953.

a. 70%. b. 80%. c. 85%. d. 87%. 4. Which of these commonly abused drugs is most likely to be prescribed by dentists? a. CNS depressants. b. Stimulants. c. Opioids. d. Nasal decongestants.

2. In 2017, what percentage of young adults aged 18 to 25 in the U.S. population was using a prescription psychotherapeutic drug in a manner or for a purpose other than that for which it was intended?

a. 11%. b. 12%. c. 13%. d. 14%.

Page 22

EliteLearning.com/Dental

Powered by FlippingBook